Skip to content

Clinical trials

Completed Observational Hyperbilirubinemia, Neonatal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperbilirubinemia, Neonatal Phase: Observational Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20103
20111
20133
20151
20161
20182
20192
20202
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oxford3
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company2
Nanjing Medical University2
University of Patras2
Ankara Training and Research Hospital1
George Washington University1
Hacettepe University1
Hillel Yaffe Medical Center1
Kanuni Sultan Suleyman Training and Research Hospital1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperbilirubinemia, Neonatal21
Hyperbilirubinemia9
Jaundice2
Jaundice, Neonatal2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.